Abstract 100: High-throughput Screening of FDA-approved Drugs Identifies Novel Inhibitors of Macropinocytosis

Aims: Macropinocytosis has been implicated in atherosclerosis, cancer, allergic disorders, and other pathologies. Unfortunately, most currently available pharmacological inhibitors of macropinocyto...